Literature DB >> 16420543

Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.

P E Molina1.   

Abstract

Traumatic injury, surgical interventions and sepsis are amongst some of the clinical conditions that result in marked activation of neuroendocrine and opiate responses aimed at restoring haemodynamic and metabolic homeostasis. The central activation of the neuroendocrine and opiate systems, known collectively as the stress response, is elicited by diverse physical stressor conditions, including ischaemia, glucopenia and inflammation. The role of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system in counterregulation of haemodynamic and metabolic alterations has been studied extensively. However, that of the endogenous opiates/opioid system is still unclear. In addition to activation of the opiate receptor through the endogenous release of opioids, pharmacotherapy with opiate receptor agonists is frequently used for sedation and analgesia of injured, septic and critically ill patients. How this affects the haemodynamic, cardiovascular, metabolic and immune responses is poorly understood. The variety of opiate receptor types, their specificity and ubiquitous location both in the central nervous system and in the periphery adds additional complicating factors to the clear understanding of their contribution to the stress response to the various physical perturbations. This review aims at discussing scientific evidence gathered from preclinical studies on the role of endogenous opioids as well as those administered as pharmacological agents on the host cardiovascular, neuroendocrine, metabolic and immune response mechanisms critical for survival from injury in perspective with clinical observations that provide parallel assessment of relevant outcome measures. When possible, the clinical relevance and corresponding scenarios where this evidence can be integrated into our understanding of the clinical implications of opiate effects will be examined. Overall, the scientific basis to enhance clinical judgment and expectations when using opioid sedation and analgesia in the management of the injured, septic or postsurgical patient will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420543     DOI: 10.1111/j.1365-2796.2005.01569.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  21 in total

Review 1.  Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-19       Impact factor: 4.147

Review 2.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

Review 3.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

Review 4.  Considerations for analgosedation and antithrombotic management during extracorporeal life support.

Authors:  Pamela K Burcham; Alan J Rozycki; Erik E Abel
Journal:  Ann Transl Med       Date:  2017-02

5.  Remifentanil/midazolam versus fentanyl/midazolam for analgesia and sedation of mechanically ventilated neonates and young infants: a randomized controlled trial.

Authors:  Lars Welzing; Andre Oberthuer; Shino Junghaenel; Urs Harnischmacher; Hartmut Stützer; Bernhard Roth
Journal:  Intensive Care Med       Date:  2012-03-29       Impact factor: 17.440

6.  The Influence of Pain and Analgesia in Rodent Models of Sepsis.

Authors:  Kelsey C Carpenter; John M Hakenjos; Christopher D Fry; Jean A Nemzek
Journal:  Comp Med       Date:  2019-06-18       Impact factor: 0.982

7.  The full-length mu-opioid receptor: a conformational study by circular dichroism in trifluoroethanol and membrane-mimetic environments.

Authors:  Isabelle Muller; Valérie Sarramégna; Marie Renault; Vincent Lafaquière; Sarra Sebai; Alain Milon; Franck Talmont
Journal:  J Membr Biol       Date:  2008-06-24       Impact factor: 1.843

8.  Urinary cortisol and catecholamine excretion after burn injury in children.

Authors:  William B Norbury; David N Herndon; Ludwik K Branski; David L Chinkes; Marc G Jeschke
Journal:  J Clin Endocrinol Metab       Date:  2008-01-22       Impact factor: 5.958

Review 9.  Opioidergic and dopaminergic modulation of respiration.

Authors:  Peter M Lalley
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

10.  Endomorphins and ohmefentanyl in the inhibition of immunosuppressant function in rat peritoneal macrophages: An experimental in vitro study.

Authors:  Wei-Yan Li; Jian-Jun Yang; Si-Hai Zhu; Hong-Jun Liu; Jian-Guo Xu
Journal:  Curr Ther Res Clin Exp       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.